Alzheimer’s Society comment on development of drugs for dementia

Alzheimer's Society comment:

'Now is not the time to back away from dementia research. Despite costing the economy more than cancer and heart disease, funding for research into dementia is only a fraction of those conditions.

Currently there are 150 times more clinical trials focusing on treating people in the late stages of cancer than Alzheimer's disease.One in three people over the age of 65 will die with dementia. More funding for research is urgently needed if we are to defeat the condition once and for all.'

Andrew Chidgey
Director of External Affairs
Alzheimer's Society

• Find out more about our research